What is ABBV's current stock price?

As of now, ABBV is trading at $225.11, with a daily change of -1.14%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

ABBV Stock Analysis & IQ Rating | AbbVie

ABBV

AbbVie

$225.11

-$2.59 | -1.14%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

alert Latest Updates

TopRated Yesterday at 01:33

continues to capture attention as AbbVie increased outlook for 2025 and expansion plans have reinforced its strong buy rating. Trading at $225.11, the stock is slightly down 1.14% on modest volume of 2.86 million shares,...

ABBV Stock IQ

Login to see AbbVie (ABBV) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

ABBV Target Price

Login to display

Strengths

ABBV Rewards

Earnings are forecast to grow

ABBV Rewards

Upgraded on attractively valued

ABBV Rewards

Investors confidence is positive

ABBV Rewards

Pays a reliable dividend

ABBV Price Performance

$218.04 (+3.24%)

$213 (+5.69%)

$190.62 (+18.09%)

$174.37 (+29.10%)

1year

6month

3month

1month

ABBV Risk Level

ABBV has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

ABBV Analysts Opinion

ABBV overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

ABBV Analysts Opinion

ABBV Analysts opinion is negative and it remained unchanged from the past 3 months

ABBV Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

90%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

60%

83%

ABBV Street Sentiment

ABBV Street Sentiment is extremely bullish and have positive views on the near-term outlook

ABBV Performance Sentiment

Sentiments overview associated with ABBV events and the stock performance.

90%

10%

Positive

Negative

26 out of 29
events present

3 out of 29
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$227.66

Resistance
Price

$211.96

Current Price Range

$244.38

Show methods +

Linked to ABBV

IQ

Close Price

Change

PFE

3.94

25.27

-1.71%

NVS

4.27

128.97

-1.04%

SNY

4.02

49.95

+0.14%

MRK

4.03

101.83

-2.87%

TEVA

4.23

26.73

-0.54%

ABBV Latest Analysis +

AbbVie: Increased Outlook For 2025 And Expansions Merit Continued Strong Buy Rating.

Today

$225.11 | -1.14%

Potential

Rating

$100 Invested In AbbVie 10 Years Ago Would Be Worth This Much Today. AbbVie (NYSE:) has outperformed the market over the past 10 years by 2.27% on an annualized basis producing an average annual return of 15.03%. Currently AbbVie has a market capitalization of $400.80 billion.

Fri Nov 28, 2025

$227.70 | +0.02%

Activity

AbbVie Scores Canadian Reimbursement Recommendations For Blockbuster Ulcerative Colitis Drug Skyrizi. On Friday ) announced two updates for .ABBV is in positive territory. Ulcerative colitis is a chronic immune-mediated inflammatory bowel disease affecting the large intestine causing persistent inflammation and ulceration of the colon’.s lining. Common symptoms include frequent diarrhea abdominal pain and rectal bleeding.Skyrizi (risankizumab) an IL-23 inhibitor received two consecutive pos

Fri Nov 28, 2025

$227.70 | +0.02%

Activity

Potential

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE. Expansion of rhCollagen and BioInk raw material sales in North American territories expected through a new partnership with a United States-based logistics center scheduled to become operational this quarter and under new commercial leadership for this regionRecent developments suggest CollPlant'.s rhCollagen will have a significant contribution towards innovation in the areas of non-animal a

Wed Nov 26, 2025

$227.66 | -1.79%

Activity

Lancement du Prix AbbVie des innovateurs en biotechnologies au Québec : AbbVie et adMare BioInnovations encouragent linnovation dans le domaine des sciences de la vie. MONTRÉ.AL 25 nov. 2025 (GLOBE NEWSWIRE) -- AbbVie (NYSE : ABBV) en collaboration avec adMare BioInnovations a annoncé aujourdhui le lancement du Prix AbbVie des innovateurs en biotechnologies visant à encourager linnovation et à soutenir la croissance dans le secteur des sciences de la vie au Québec.

Tue Nov 25, 2025

$231.80 | +1.03%

Activity

AbbVie and adMare BioInnovations Foster Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators Award in Quebec. MONTREAL Nov. 25 2025 (GLOBE NEWSWIRE) -- Today AbbVie (NYSE: ABBV) jointly with the adMare BioInnovations announced the launch of the AbbVie Biotech Innovators Award a prize to help foster innovation and support growth in Quebecs life sciences sector.

Tue Nov 25, 2025

$231.80 | +1.03%

Activity

AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It. AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore it is wise to be aware of the facts that can impact the stocks prospects.

Wed Nov 19, 2025

$232.91 | -0.40%

Activity

AbbVie Stock Rebounds After Q3 Dip: Time to Buy Hold or Sell?. ABBV rebounds after its Q3 dip as strong immunology and neuroscience growth offset Humira erosion and aesthetics weakness.

Wed Nov 19, 2025

$232.91 | -0.40%

Momentum

Potential

AbbVie Genmab win FDA label expansion for Epkinly in follicular lymphoma.

Tue Nov 18, 2025

$233.87 | -0.06%

Activity

Heres How Neuroscience Drugs Aided AbbVies Top-line Growth in Q3. ABBVs neuroscience drugs drive strong Q3 momentum with rising Botox Therapeutic sales migraine therapies and new PD treatments fueling growth.

Tue Nov 18, 2025

$233.87 | -0.06%

Momentum

FAQ About ABBV Stock Insights

What is ABBV current stock price?

What are ABBV stock strengths?

What is ABBV Risk Level?

What is ABBV market cap and volume?

What is ABBV current Stock IQ?

Should I buy ABBV stock right now?

Is ABBV a Strong Buy right now?

What does a 'Strong Buy' rating mean for ABBV?

What does a 'Strong Sell' rating mean for ABBV?

What factors influence ABBV's Stock IQ?

Explore our ABBV Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored ABBV Stock Strategies
Effective Risk Management

FIND US ON

Receive our ABBV Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

ABBV

AbbVie

Current Price

$225.11

-$2.59 | -1.14%

52W High

$244.81

MKT CAP

$397.86B

52W Low

$164.39

VOL

$2.86M

P/E Ratio

169.85

AVG VOL

$5.87M

RSI

46.52

TREND

Sideways

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

ABBV Rewards

Earnings are forecast to grow

ABBV Rewards

Upgraded on attractively valued

ABBV Rewards

Investors confidence is positive

ABBV Rewards

Pays a reliable dividend

Linked to ABBV

Symbol

IQ

Close

Change

PFE

3.94

25.27

-1.71%

NVS

4.27

128.97

-1.04%

SNY

4.02

49.95

+0.14%

MRK

4.03

101.83

-2.87%

TEVA

4.23

26.73

-0.54%

ABBV Price Performance

$218.04 (+3.24%)

$213 (+5.69%)

$190.62 (+18.09%)

$174.37 (+29.10%)

1year

6month

3month

1month

ABBV Analysts Opinion

ABBV Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

ABBV Analysts Opinion

ABBV Analysts opinion is negative and it remained unchanged from the past 3 months

ABBV Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

90%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

60%

83%

ABBV Street Sentiment

ABBV Street Sentiment is extremely bullish and have positive views on the near-term outlook

ABBV Risk Level

ABBV has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

ABBV Performance Sentiment

Sentiments overview associated with ABBV events and the stock performance.

90%

10%

Positive

Negative

26 out of 29
events present

3 out of 29
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$227.66

Resistance
Price

$211.96

Current Price Range

$244.38

Show methods +

ABBV Stock IQ

Login to unlock AbbVie (ABBV) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

ABBV Latest Analysis

TopRated Yesterday at 01:33

continues to capture attention as AbbVie increased outlook for 2025 and expansion plans have reinforced its strong buy rating. Trading at $225.11, the stock is slightly down 1.14% on modest volume of 2.86 million shares,...

AbbVie: Increased Outlook For 2025 And Expansions Merit Continued Strong Buy Rating.

Today

$225.11 | -1.14%

Potential

Rating

$100 Invested In AbbVie 10 Years Ago Would Be Worth This Much Today. AbbVie (NYSE:) has outperformed the market over the past 10 years by 2.27% on an annualized basis producing an average annual return of 15.03%. Currently AbbVie has a market capitalization of $400.80 billion.

Fri Nov 28, 2025

$227.70 | +0.02%

Activity

AbbVie Scores Canadian Reimbursement Recommendations For Blockbuster Ulcerative Colitis Drug Skyrizi. On Friday ) announced two updates for .ABBV is in positive territory. Ulcerative colitis is a chronic immune-mediated inflammatory bowel disease affecting the large intestine causing persistent inflammation and ulceration of the colon’.s lining. Common symptoms include frequent diarrhea abdominal pain and rectal bleeding.Skyrizi (risankizumab) an IL-23 inhibitor received two consecutive pos

Fri Nov 28, 2025

$227.70 | +0.02%

Activity

Potential

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE. Expansion of rhCollagen and BioInk raw material sales in North American territories expected through a new partnership with a United States-based logistics center scheduled to become operational this quarter and under new commercial leadership for this regionRecent developments suggest CollPlant'.s rhCollagen will have a significant contribution towards innovation in the areas of non-animal a

Wed Nov 26, 2025

$227.66 | -1.79%

Activity

Lancement du Prix AbbVie des innovateurs en biotechnologies au Québec : AbbVie et adMare BioInnovations encouragent linnovation dans le domaine des sciences de la vie. MONTRÉ.AL 25 nov. 2025 (GLOBE NEWSWIRE) -- AbbVie (NYSE : ABBV) en collaboration avec adMare BioInnovations a annoncé aujourdhui le lancement du Prix AbbVie des innovateurs en biotechnologies visant à encourager linnovation et à soutenir la croissance dans le secteur des sciences de la vie au Québec.

Tue Nov 25, 2025

$231.80 | +1.03%

Activity

AbbVie and adMare BioInnovations Foster Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators Award in Quebec. MONTREAL Nov. 25 2025 (GLOBE NEWSWIRE) -- Today AbbVie (NYSE: ABBV) jointly with the adMare BioInnovations announced the launch of the AbbVie Biotech Innovators Award a prize to help foster innovation and support growth in Quebecs life sciences sector.

Tue Nov 25, 2025

$231.80 | +1.03%

Activity

AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It. AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore it is wise to be aware of the facts that can impact the stocks prospects.

Wed Nov 19, 2025

$232.91 | -0.40%

Activity

AbbVie Stock Rebounds After Q3 Dip: Time to Buy Hold or Sell?. ABBV rebounds after its Q3 dip as strong immunology and neuroscience growth offset Humira erosion and aesthetics weakness.

Wed Nov 19, 2025

$232.91 | -0.40%

Momentum

Potential

AbbVie Genmab win FDA label expansion for Epkinly in follicular lymphoma.

Tue Nov 18, 2025

$233.87 | -0.06%

Activity

Heres How Neuroscience Drugs Aided AbbVies Top-line Growth in Q3. ABBVs neuroscience drugs drive strong Q3 momentum with rising Botox Therapeutic sales migraine therapies and new PD treatments fueling growth.

Tue Nov 18, 2025

$233.87 | -0.06%

Momentum

Discover ABBV Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of ABBV. We're here to help you make informed investment decisions today.

FIND US ON

Receive our ABBV Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ABBV Stock trends

ABBV Stock performance

ABBV Stock analysis

ABBV investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ABBV

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ABBV

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

ABBV Stock Analysis & IQ Rating | AbbVie

ABBV Stock IQ

ABBV Target Price

ABBV Risk Level

ABBV Analysts Opinion

ABBV Street Sentiment

ABBV Performance Sentiment

Technical Price Levels

Explore our ABBV Stock insights

Receive our ABBV Daily Alerts

ABBV Street Sentiment

ABBV Risk Level

Technical Price Levels

Discover ABBV Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of ABBV. We're here to help you make informed investment decisions today.

Receive our ABBV Daily Alerts

ABBV Runner Alarm